MARKET

RDPTF

RDPTF

Radiopharm Theranostics Ltd
OTCPK
0.0014
NaN%
Closed 09:30 09/29 EDT
OPEN
--
PREV CLOSE
0.0014
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.020
52 WEEK LOW
0.0014
MARKET CAP
6.60M
P/E (TTM)
-0.1129
1D
5D
1M
3M
1Y
5Y
1D
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
Barchart · 09/09 06:00
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
Barchart · 08/20 06:00
Radiopharm Theranostics announces $4.1M registered direct offering and up to A$12.7M Australian financing
Seeking Alpha · 07/24 13:00
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
Barchart · 07/22 06:05
Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases
Barchart · 04/16 06:00
About RDPTF
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.

Webull offers Radiopharm Theranostics Ltd stock information, including OTCPK: RDPTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDPTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDPTF stock methods without spending real money on the virtual paper trading platform.